Proactive Investors - Run By Investors For Investors

Cello Health launches in Germany with new Berlin office, appoints regional directors

Jane Shirley, chief executive of the healthcare-focused consultancy, said the new branch in mainland Europe would provide additional ground support to its continental clients
German flag
The Berlin office will headquarter the company's new entity, Cello Health Insight Germany

Cello Health PLC (LON:CLL) has launched its German branch with a new office in Berlin while also appointing two regional directors.

The healthcare-focused consultancy said on Monday that the two regional directors were Heike Tombrink, who was also appointed head of Cello Health Insight Germany, and Matthias Heurich, who would be supporting digital innovation.

READ: Cello Health expects 'robust' profits growth in first half

Tombrink has prior experience in leading small and large teams in and outside of matrix organisations  - that is where some individuals sometimes report to more than one leader - while Heurich specialises in applied machine learning and artificial intelligence for natural language processing.

Commenting on the news, Jane Shirley, Cello’s chief executive, said the new branch in mainland Europe would bring “a number of benefits” while also serving as a first step in providing additional ground support for the company’s European clients and allowing access to a wider talent pool.

In lunchtime trading on Tuesday, Cello shares were 1.2% lower at 122p.

View full CLL profile View Profile

Cello Health PLC Timeline

Video
April 11 2019
Big Picture
March 22 2019

Related Articles

Live Company
July 05 2019
In June 2019 the company signed a five-year deal to create tours themed around properties owned by children’s television network Nickelodeon
pills
March 22 2019
The healthcare-focused advisory group boasts good levels of forward bookings thanks to several new business wins at the beginning of 2019
marketing
June 26 2019
Speaking in April, Next’s chief executive Tim Dyson said the company had “lots of scope” for acquisitions in the coming year

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use